App-Quantinova.ai

The simple 10-item PARC tool predicts childhood asthma in an external validation cohort

Eva Sophie Lunde Pedersen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Management of tuberculosis in the European Union: a multicentre audit

Senia Rosales-Klintz - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Performance of Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) with Rapid On-Site Evaluation (ROSE) in the pathological subtyping and molecular testing of non-small cell lung cancer (NSCLC) at a UK institute

Christopher Craig - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Non Small Cell Lung cancer

N/A

Investigating effects of nintedanib on biomarkers of ECM turnover in patients with IPF: the INMARK study

Toby Maher - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Peritoneal colorectal carcinomatosis

Nintedanib

Low dehydroepiandrosterone sulfate (DHEA-S) is associated with worse lung function in women.

Giancarlo Pesce - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

DHEA-S

Safety of benzodiazepines and opioids in interstitial lung disease: national prospective study

Sabrina Bajwah - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Update of the British Occupational Health Research Foundation (BOHRF) guidelines on occupational asthma.

Sara De Matteis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Inspiratory muscle effort, perfusion and oxygenation responses to inspiratory muscle training (IMT) with Tapered Flow Resistive Loading (TFRL) and Normocapnic Hyperpnea (NH) in COPD.

Zafeiris Louvaris - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening

Dave Singh - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

fluticasone furoate/umeclidinium/vilanterol

Multiple ascending inhaled doses of AZD8871 in healthy males

Victor Balaguer Sole - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

An Evaluation of a Smoking Cessation Service in a Regional Cardio-Thoracic Centre.

Deborah Beach - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Champix

Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST

William Busse - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Dupilumab

Asthma in cleaners: a distinct phenotype?

Collin Brooks - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Asthma

N/A

Management of children and young people (CYP) in London with asthma: a clinical audit report.

Mark L. Levy - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review

Wilhelmine Meeraus - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Impact of Community Respiratory Team on individual hospital admissions and region based improvements.

Jennifer Macfie - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Caucasian small for gestational age infants with bronchopulmonary dysplasia require longer, and more intensive treatment for their disease than appropriate for gestational age, and non-Caucasian counterparts.

Eleanor Grimley - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Chronic cough is associated with an increased risk of hypertension

Rachel Dockry - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery

Sergey E. Borisov - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

Bedaquiline

Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension

Sofia Pedersen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

LY2928057

Filters

45280 Abstracts